Skip to main content

Table 5 Comparison of the expression levels of immune cytokines in the two groups of patients before and after treatment[\(\overline{x}\) ± s]

From: Clinical outcomes and safety of combined calcitriol and bisphosphonates in treating postmenopausal osteoporosis: a retrospective cohort study

Group

N

IL-6(ng/L)

IL-10(ng/L)

TGF-β1(ng/L)

TNF-α (ng/L)

Before treatment

After treatment

Before treatment

After treatment

Before treatment

After treatment

Before treatment

After treatment

C group

76

125.26 ± 12.38

110.22 ± 11.65a

29.37 ± 3.51

36.48 ± 3.87a

5.28 ± 1.08

6.34 ± 1.32a

5.88 ± 1.04

4.55 ± 0.93a

R group

76

125.34 ± 12.32

84.21 ± 8.17b

29.45 ± 3.17

46.35 ± 5.66b

5.26 ± 1.01

8.08 ± 2.25b

5.83 ± 1.05

3.18 ± 0.56b

t

 

0.040

15.935

0.147

12.549

0.118

5.815

0.295

11.002

P

 

 > 0.05

 < 0.01

 > 0.05

 < 0.01

 > 0.05

 < 0.01

 > 0.05

 < 0.01

  1. Comparison before and after treatment in the control group, aP < 0.05; Comparison of research group before and after treatment, bP < 0.05